(1)
Service de Gynécologie et Obstétrique, Centre d’Études Périnatales de l’Océan Indien (CEPOI) – EA7388, CHU Réunion, Hôpital Félix Guyon, Saint Denis de la Réunion, France
We have published [1] a retrospective monocentric single operator series of all laparoscopic sacrocolpopexies performed for genital prolapse, according to the double mesh technique described in this book at the unit of Gynecology of the University Hospital of Caen between January 1993 and December 2002. We excluded patients who had laparoscopic mesh suspension for Masters and Allen Syndrome [2] as well as those who had a conversion to laparotomy for any reason. Patients were found through the French hospital discharge data base, the Programme of Medicalisation of Information System (PMSI) and all the hospital files as well as the operative and consultation reports were reviewed by two independent investigators.
The procedures have all been performed by me using the same surgical technique previously described for first 44 women [3, 4]. Laparoscopic Burch colposuspension [5] was almost systematically performed between 1993 and 2000. Later, TVT was used but only in case of objective stress urinary incontinence (SUI).
The study has been conducted in three steps. First step was the analysis of the medical files in order to gather pre, per and post operative data like BMI, previous history, staging of the POP according to the International Continence Society (ICS): Pelvic Organ Prolapse Quantification POP-Q [6], SUI, surgical report, associated procedures (hysterectomy, ovariectomy, etc.), complications. Second step was an observational descriptive evaluation. All the patients were directly contacted by phone first (to get their agreement participate, confirmed later by signature) and by mail (questionnaire). Quality of life (QoL) has been evaluated with the French validated short version of Pelvic Floor Distress Inventory 20 (PDFI 20) with the three sub groups of questions: Urinary Distress Inventory (UDI 6), Colo-Rectal and Anal Distress Inventory (CRADI 8) and Pelvic Organ Prolaps Distress Inventory (POPDI 6). Pelvic Floor Impact Questionnaire (PFIQ 7) has also been completed. This questionnaire has also three sub groups: Urinary Impact Questionnaire (UIQ 7), Colo-Rectal and Anal Impact Questionnaire (CRAIQ 7) et Pelvic Organ Prolaps Impact Questionnaire (POPIQ 7) [7, 8]. Last step was a clinical assessment of the anatomy. This examination, performed by an independent gynecologist (EM), was standardized to assess the anatomical defects according to ICS POP-Q. For the purpose of statistical data analysis, qualitative variables were described as frequency and percentages and quantitative ones as mean (ranges). To analyse risk factors for relapse we used chi-squares (or Fisher exact test) or t-test (or Mann-Whitney tests), as appropriate. The level of significance was set to 0.05 for these main analyses (bi sided tests). Analyses were carried out at the “Unité de Biostatistique et Recherche Clinique” (Caen University Hospital) using SPPS software vs 19.
9.1 Our Results
Out of the 104 women who had a LSCP between 1993 and 2002, six patients have deceased (5.8%) and 18 (17.3%) were impossible to contact despite repeated attempts. Eighty women were contacted and all of them accepted to participate to the study and to answer the questionnaires. Fifty-one patients accepted to meet the gynecologist for a clinical assessment (Fig. 9.1).
Fig. 9.1
Population of the study
Average follow up was 13.6 years (range 11–20 years). Main characteristics of the population are described in Table 9.1. Preoperatively, 55% of patients showed a prolapse of the three compartments (n = 44) and 45% of complained of SUI (n = 36). Preoperative characteristics are on Fig. 9.2. Average operation duration, including associated procedures, was 130 min (60–220). Subtotal hysterectomy was performed in 3 patients (3.8%) and SUI repair in 50 patients (62.5%). Eight preoperative complications (10%) occurred: six bladder injuries and two vaginal injuries. Short term results have been published in 2001 for the 44 first patient of this series [10].
Table 9.1
Clinical characteristics of the population of the study
Age at LSCP | 54.4 [35–77] |
---|---|
Age at study | 69.1 [46–91] |
Body mass index (kg/m2) | 23.8 [18.4–36.3] |
Parity | 2.9 [1–7] |
Ménopausal n (%) | 52 (65%) |
Previous hysterectomy n (%) Abdominal Vaginal | 19 (23.8%) 11 (13.8%) 8 (10%) |
Previous POP repair n (%) Abdominal Vaginal | 16 (20%) 3 (3.8%) 13 (16.3%) |
Previous SUI repair n (%) | 9 (11.3%) |
Pre operative symptoms n (%) | |
Pelvic heaviness Urinary symptoms Bowel symptoms | 79 (98.8%) 38 (47.5%) 6 (7.5%) |
Fig. 9.2
Preoperative clinical evaluation (POP-Q)
9.1.1 Long Term Anatomic Results
After average follow up of 13.6 years (11–20), 20 women have been re operated for recurrence (25%). In 19 of these, only one compartment recurred. In 11 patients (55% of recurrences), it appeared to be a cystocele, in 7 patients (35%) a rectocele and in 2 patients (10%) a uterine prolapse. Recurrence happened after 5.9 years for cystocele, 7.4 years for rectocele and 7.3 tears for vault or uterine descent. POP-Q staging of the 51 patients that could be examined clinically is on Figs. 9.2 and 9.3. Eleven women (21.5%) had a recurrence (POP-Q = 2 or more). In seven women (63.6%), it was a cystocele. Recurrence was asymptomatic in eight women (72.7%). Six of the patients with recurrence have had a second operation during the follow up period and four of them presented a recurrence on the compartment that has been reoperated (always cystocele). Among the 80 women of our study, 15 (18.8%) had a SUI repair during the follow up period after 6.4 years average. The SUI repair was associated with POP repair in five women (33.3%). At the time of the evaluation, five patients complained of de novo SUI.
Fig. 9.3
Long term follow up anatomical results (POP-Q)
9.1.2 Risk Factors for Recurrence
We were looking for correlations between previous history, BMI, initial POP-Q stage and recurrence. The only significant correlation was with the presence of a large cystocele at the beginning (Tables 9.2 and 9.3).
Table 9.2
Risk factors for recurrence
n/N | (%) | p | |
---|---|---|---|
Multiparity | |||
yes no | 20/76 0/4 | 26.3% 0% | 0.568 |
Menopausal | |||
yes No | 14/52 6/28 | 26.9% 21.4% | 0.852 |
Previous hysterectomy | |||
yes No | 4/19 16/61 | 21.1% 26.2% | 1000 |
Previous POP repair | |||
yes No | 1/15 19/65 | 6.7% 29.2% | 0.331 |
Uterie descent stage 3 | |||
yes No | 13/43 3/16 | 30.2% 18.8% | 0.517 |
Cystocele stage 3 | |||
yes No | 17/51 3/29 | 33.3% 10.3% | 0.049 |
Rectocele stage 3 | |||
yes No | 16/60 4/20 | 26.7% 20% | 0.883 |
Vault prolapse stage 3 | |||
yes no | 4/14 1/5 | 28.6% 20% | 1000 |
Hysterectomy during LSCP | |||
yes No | 0/3 20/77 | 0% 25.9% | 0.563 |
Table 9.3
BMI and recurrence
N | average | Standard deviation | p Mann-Whitney | |
---|---|---|---|---|
BMI ≥ 25 | ||||
yes No | 20 80 | 24 23.4 | 3.2 3.2 | 0.225 |
9.1.3 Long Term Functional Results
Functional results are described on Table 9.4 and evolution of symptoms and QoL on Table 9.5. Urinary symptoms were mainly urinary incontinence and/or bladder over activity. Recurrence happened after 8.9 years average. In 66.7% of women (n = 10), no recurrence of POP was associated. After analyzing the QoL questionnaires, 92.5% of patients had no more urinary symptom (UDI-7 score of 20/100) and 93.8% had no impairment of QoL (UDI score 10.8/100). Pelvic symptoms were mainly heaviness and discomfort. Recurrence happened after 8.9 years average. At the time of our study, 96.3% of women presented no symptom (POPDI-6 score 14/100) and 95% had no impairment of QoL (POPQI-7 Score 7.5/100). Rectal symptoms were mainly constipation and/or obstructed defecation and recurrence happened after 6.8 years average (1–11 years). In 80% of women, constipation was associated with POP recurrence. 86.3% of patients didn’t complain of bowel symptoms (CRADI-8 score 20.2/100) and 93.1% had no impairment of QoL (CRAIQ-7 score 12/100).
Table 9.4
Long term functional results
Urinary symptoms
Stay updated, free articles. Join our Telegram channelFull access? Get Clinical TreeGet Clinical Tree app for offline access |
---|